Global Artificial Cardiopulmonary Machine Market Growth 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Artificial Cardiopulmonary Machine will have significant change from previous year. By the most conservative estimates of global Artificial Cardiopulmonary Machine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Artificial Cardiopulmonary Machine market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Cardiopulmonary Machine market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Artificial Cardiopulmonary Machine, covering the supply chain analysis, impact assessment to the Artificial Cardiopulmonary Machine market size growth rate in several scenarios, and the measures to be undertaken by Artificial Cardiopulmonary Machine companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Single Roller Pump HLM
Double Roller Pump HLM
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
LivaNova (Sorin)
Getinge (Maquet)
Terumo CV Group
Braile Biomedica
Medtronic
Tianjin Medical
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Artificial Cardiopulmonary Machine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Artificial Cardiopulmonary Machine market by identifying its various subsegments.
Focuses on the key global Artificial Cardiopulmonary Machine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Artificial Cardiopulmonary Machine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Artificial Cardiopulmonary Machine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Artificial Cardiopulmonary Machine?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Artificial Cardiopulmonary Machine Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artificial Cardiopulmonary Machine Consumption 2015-2025
2.1.2 Artificial Cardiopulmonary Machine Consumption CAGR by Region
2.2 Artificial Cardiopulmonary Machine Segment by Type
2.2.1 Single Roller Pump HLM
2.2.2 Double Roller Pump HLM
2.3 Artificial Cardiopulmonary Machine Consumption by Type
2.3.1 Global Artificial Cardiopulmonary Machine Consumption Market Share by Type (2015-2020)
2.3.2 Global Artificial Cardiopulmonary Machine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Artificial Cardiopulmonary Machine Sale Price by Type (2015-2020)
2.4 Artificial Cardiopulmonary Machine Segment by Application
2.4.1 Cardiac Surgery
2.4.2 Lung Transplant Operation
2.4.3 Acute Respiratory Failure Treatment
2.4.4 Others
2.5 Artificial Cardiopulmonary Machine Consumption by Application
2.5.1 Global Artificial Cardiopulmonary Machine Consumption Market Share by Type (2015-2020)
2.5.2 Global Artificial Cardiopulmonary Machine Value and Market Share by Type (2015-2020)
2.5.3 Global Artificial Cardiopulmonary Machine Sale Price by Type (2015-2020)
3 Global Artificial Cardiopulmonary Machine by Company
3.1 Global Artificial Cardiopulmonary Machine Sales Market Share by Company
3.1.1 Global Artificial Cardiopulmonary Machine Sales by Company (2018-2020)
3.1.2 Global Artificial Cardiopulmonary Machine Sales Market Share by Company (2018-2020)
3.2 Global Artificial Cardiopulmonary Machine Revenue Market Share by Company
3.2.1 Global Artificial Cardiopulmonary Machine Revenue by Company (2018-2020)
3.2.2 Global Artificial Cardiopulmonary Machine Revenue Market Share by Company (2018-2020)
3.3 Global Artificial Cardiopulmonary Machine Sale Price by Company
3.4 Global Artificial Cardiopulmonary Machine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Artificial Cardiopulmonary Machine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Artificial Cardiopulmonary Machine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Artificial Cardiopulmonary Machine by Regions
4.1 Artificial Cardiopulmonary Machine by Regions
4.2 Americas Artificial Cardiopulmonary Machine Consumption Growth
4.3 APAC Artificial Cardiopulmonary Machine Consumption Growth
4.4 Europe Artificial Cardiopulmonary Machine Consumption Growth
4.5 Middle East & Africa Artificial Cardiopulmonary Machine Consumption Growth
5 Americas
5.1 Americas Artificial Cardiopulmonary Machine Consumption by Countries
5.1.1 Americas Artificial Cardiopulmonary Machine Consumption by Countries (2015-2020)
5.1.2 Americas Artificial Cardiopulmonary Machine Value by Countries (2015-2020)
5.2 Americas Artificial Cardiopulmonary Machine Consumption by Type
5.3 Americas Artificial Cardiopulmonary Machine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Artificial Cardiopulmonary Machine Consumption by Regions
6.1.1 APAC Artificial Cardiopulmonary Machine Consumption by Regions (2015-2020)
6.1.2 APAC Artificial Cardiopulmonary Machine Value by Regions (2015-2020)
6.2 APAC Artificial Cardiopulmonary Machine Consumption by Type
6.3 APAC Artificial Cardiopulmonary Machine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Artificial Cardiopulmonary Machine by Countries
7.1.1 Europe Artificial Cardiopulmonary Machine Consumption by Countries (2015-2020)
7.1.2 Europe Artificial Cardiopulmonary Machine Value by Countries (2015-2020)
7.2 Europe Artificial Cardiopulmonary Machine Consumption by Type
7.3 Europe Artificial Cardiopulmonary Machine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Artificial Cardiopulmonary Machine by Countries
8.1.1 Middle East & Africa Artificial Cardiopulmonary Machine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Artificial Cardiopulmonary Machine Value by Countries (2015-2020)
8.2 Middle East & Africa Artificial Cardiopulmonary Machine Consumption by Type
8.3 Middle East & Africa Artificial Cardiopulmonary Machine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Artificial Cardiopulmonary Machine Distributors
10.3 Artificial Cardiopulmonary Machine Customer
11 Global Artificial Cardiopulmonary Machine Market Forecast
11.1 Global Artificial Cardiopulmonary Machine Consumption Forecast (2021-2025)
11.2 Global Artificial Cardiopulmonary Machine Forecast by Regions
11.2.1 Global Artificial Cardiopulmonary Machine Forecast by Regions (2021-2025)
11.2.2 Global Artificial Cardiopulmonary Machine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Artificial Cardiopulmonary Machine Forecast by Type
11.8 Global Artificial Cardiopulmonary Machine Forecast by Application
12 Key Players Analysis
12.1 LivaNova (Sorin)
12.1.1 Company Information
12.1.2 Artificial Cardiopulmonary Machine Product Offered
12.1.3 LivaNova (Sorin) Artificial Cardiopulmonary Machine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 LivaNova (Sorin) Latest Developments
12.2 Getinge (Maquet)
12.2.1 Company Information
12.2.2 Artificial Cardiopulmonary Machine Product Offered
12.2.3 Getinge (Maquet) Artificial Cardiopulmonary Machine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Getinge (Maquet) Latest Developments
12.3 Terumo CV Group
12.3.1 Company Information
12.3.2 Artificial Cardiopulmonary Machine Product Offered
12.3.3 Terumo CV Group Artificial Cardiopulmonary Machine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Terumo CV Group Latest Developments
12.4 Braile Biomedica
12.4.1 Company Information
12.4.2 Artificial Cardiopulmonary Machine Product Offered
12.4.3 Braile Biomedica Artificial Cardiopulmonary Machine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Braile Biomedica Latest Developments
12.5 Medtronic
12.5.1 Company Information
12.5.2 Artificial Cardiopulmonary Machine Product Offered
12.5.3 Medtronic Artificial Cardiopulmonary Machine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Medtronic Latest Developments
12.6 Tianjin Medical
12.6.1 Company Information
12.6.2 Artificial Cardiopulmonary Machine Product Offered
12.6.3 Tianjin Medical Artificial Cardiopulmonary Machine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Tianjin Medical Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Artificial Cardiopulmonary Machine Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Artificial Cardiopulmonary Machine Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Artificial Cardiopulmonary Machine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Single Roller Pump HLM
Table 7. Major Players of Double Roller Pump HLM
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Artificial Cardiopulmonary Machine Consumption Market Share by Type (2015-2020)
Table 10. Global Artificial Cardiopulmonary Machine Revenue by Type (2015-2020) ($ million)
Table 11. Global Artificial Cardiopulmonary Machine Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Artificial Cardiopulmonary Machine Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Artificial Cardiopulmonary Machine Consumption Market Share by Application (2015-2020)
Table 15. Global Artificial Cardiopulmonary Machine Value by Application (2015-2020)
Table 16. Global Artificial Cardiopulmonary Machine Value Market Share by Application (2015-2020)
Table 17. Global Artificial Cardiopulmonary Machine Sale Price by Application (2015-2020)
Table 18. Global Artificial Cardiopulmonary Machine Sales by Company (2017-2019) (K Units)
Table 19. Global Artificial Cardiopulmonary Machine Sales Market Share by Company (2017-2019)
Table 20. Global Artificial Cardiopulmonary Machine Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Artificial Cardiopulmonary Machine Revenue Market Share by Company (2017-2019)
Table 22. Global Artificial Cardiopulmonary Machine Sale Price by Company (2017-2019)
Table 23. Global Artificial Cardiopulmonary Machine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Artificial Cardiopulmonary Machine Products Offered
Table 25. Artificial Cardiopulmonary Machine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Artificial Cardiopulmonary Machine Consumption by Regions 2015-2020 (K Units)
Table 27. Global Artificial Cardiopulmonary Machine Consumption Market Share by Regions 2015-2020
Table 28. Global Artificial Cardiopulmonary Machine Value by Regions 2015-2020 ($ Millions)
Table 29. Global Artificial Cardiopulmonary Machine Value Market Share by Regions 2015-2020
Table 30. Americas Artificial Cardiopulmonary Machine Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Artificial Cardiopulmonary Machine Consumption Market Share by Countries (2015-2020)
Table 32. Americas Artificial Cardiopulmonary Machine Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Artificial Cardiopulmonary Machine Value Market Share by Countries (2015-2020)
Table 34. Americas Artificial Cardiopulmonary Machine Consumption by Type (2015-2020) (K Units)
Table 35. Americas Artificial Cardiopulmonary Machine Consumption Market Share by Type (2015-2020)
Table 36. Americas Artificial Cardiopulmonary Machine Consumption by Application (2015-2020) (K Units)
Table 37. Americas Artificial Cardiopulmonary Machine Consumption Market Share by Application (2015-2020)
Table 38. APAC Artificial Cardiopulmonary Machine Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Artificial Cardiopulmonary Machine Consumption Market Share by Countries (2015-2020)
Table 40. APAC Artificial Cardiopulmonary Machine Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Artificial Cardiopulmonary Machine Value Market Share by Regions (2015-2020)
Table 42. APAC Artificial Cardiopulmonary Machine Consumption by Type (2015-2020) (K Units)
Table 43. APAC Artificial Cardiopulmonary Machine Consumption Market Share by Type (2015-2020)
Table 44. APAC Artificial Cardiopulmonary Machine Consumption by Application (2015-2020) (K Units)
Table 45. APAC Artificial Cardiopulmonary Machine Consumption Market Share by Application (2015-2020)
Table 46. Europe Artificial Cardiopulmonary Machine Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Artificial Cardiopulmonary Machine Consumption Market Share by Countries (2015-2020)
Table 48. Europe Artificial Cardiopulmonary Machine Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Artificial Cardiopulmonary Machine Value Market Share by Countries (2015-2020)
Table 50. Europe Artificial Cardiopulmonary Machine Consumption by Type (2015-2020) (K Units)
Table 51. Europe Artificial Cardiopulmonary Machine Consumption Market Share by Type (2015-2020)
Table 52. Europe Artificial Cardiopulmonary Machine Consumption by Application (2015-2020) (K Units)
Table 53. Europe Artificial Cardiopulmonary Machine Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Artificial Cardiopulmonary Machine Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Artificial Cardiopulmonary Machine Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Artificial Cardiopulmonary Machine Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Artificial Cardiopulmonary Machine Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Artificial Cardiopulmonary Machine Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Artificial Cardiopulmonary Machine Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Artificial Cardiopulmonary Machine Consumption by Application (2015-2020) (K Units)
Table 61. Middle East & Africa Artificial Cardiopulmonary Machine Consumption Market Share by Application (2015-2020)
Table 62. Artificial Cardiopulmonary Machine Distributors List
Table 63. Artificial Cardiopulmonary Machine Customer List
Table 64. Global Artificial Cardiopulmonary Machine Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Artificial Cardiopulmonary Machine Consumption Market Forecast by Regions
Table 66. Global Artificial Cardiopulmonary Machine Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Artificial Cardiopulmonary Machine Value Market Share Forecast by Regions
Table 68. Global Artificial Cardiopulmonary Machine Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Artificial Cardiopulmonary Machine Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Artificial Cardiopulmonary Machine Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Artificial Cardiopulmonary Machine Value Market Share Forecast by Type (2021-2025)
Table 72. Global Artificial Cardiopulmonary Machine Consumption Forecast by Application (2021-2025) (K Units)
Table 73. Global Artificial Cardiopulmonary Machine Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Artificial Cardiopulmonary Machine Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Artificial Cardiopulmonary Machine Value Market Share Forecast by Application (2021-2025)
Table 76. LivaNova (Sorin) Product Offered
Table 77. LivaNova (Sorin) Artificial Cardiopulmonary Machine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 78. LivaNova (Sorin) Main Business
Table 79. LivaNova (Sorin) Latest Developments
Table 80. LivaNova (Sorin) Basic Information, Company Total Revenue (in $ million), Artificial Cardiopulmonary Machine Manufacturing Base, Sales Area and Its Competitors
Table 81. Getinge (Maquet) Product Offered
Table 82. Getinge (Maquet) Artificial Cardiopulmonary Machine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. Getinge (Maquet) Main Business
Table 84. Getinge (Maquet) Latest Developments
Table 85. Getinge (Maquet) Basic Information, Company Total Revenue (in $ million), Artificial Cardiopulmonary Machine Manufacturing Base, Sales Area and Its Competitors
Table 86. Terumo CV Group Product Offered
Table 87. Terumo CV Group Artificial Cardiopulmonary Machine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. Terumo CV Group Main Business
Table 89. Terumo CV Group Latest Developments
Table 90. Terumo CV Group Basic Information, Company Total Revenue (in $ million), Artificial Cardiopulmonary Machine Manufacturing Base, Sales Area and Its Competitors
Table 91. Braile Biomedica Product Offered
Table 92. Braile Biomedica Artificial Cardiopulmonary Machine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. Braile Biomedica Main Business
Table 94. Braile Biomedica Latest Developments
Table 95. Braile Biomedica Basic Information, Company Total Revenue (in $ million), Artificial Cardiopulmonary Machine Manufacturing Base, Sales Area and Its Competitors
Table 96. Medtronic Product Offered
Table 97. Medtronic Artificial Cardiopulmonary Machine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. Medtronic Main Business
Table 99. Medtronic Latest Developments
Table 100. Medtronic Basic Information, Company Total Revenue (in $ million), Artificial Cardiopulmonary Machine Manufacturing Base, Sales Area and Its Competitors
Table 101. Tianjin Medical Product Offered
Table 102. Tianjin Medical Artificial Cardiopulmonary Machine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. Tianjin Medical Main Business
Table 104. Tianjin Medical Latest Developments
Table 105. Tianjin Medical Basic Information, Company Total Revenue (in $ million), Artificial Cardiopulmonary Machine Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Artificial Cardiopulmonary Machine
Figure 2. Artificial Cardiopulmonary Machine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Artificial Cardiopulmonary Machine Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Artificial Cardiopulmonary Machine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Single Roller Pump HLM
Figure 7. Product Picture of Double Roller Pump HLM
Figure 8. Global Artificial Cardiopulmonary Machine Consumption Market Share by Type (2015-2020)
Figure 9. Global Artificial Cardiopulmonary Machine Value Market Share by Type (2015-2020)
Figure 10. Artificial Cardiopulmonary Machine Consumed in Cardiac Surgery
Figure 11. Global Artificial Cardiopulmonary Machine Market: Cardiac Surgery (2015-2020) (K Units)
Figure 12. Global Artificial Cardiopulmonary Machine Market: Cardiac Surgery (2015-2020) ($ Millions)
Figure 13. Artificial Cardiopulmonary Machine Consumed in Lung Transplant Operation
Figure 14. Global Artificial Cardiopulmonary Machine Market: Lung Transplant Operation (2015-2020) (K Units)
Figure 15. Global Artificial Cardiopulmonary Machine Market: Lung Transplant Operation (2015-2020) ($ Millions)
Figure 16. Artificial Cardiopulmonary Machine Consumed in Acute Respiratory Failure Treatment
Figure 17. Global Artificial Cardiopulmonary Machine Market: Acute Respiratory Failure Treatment (2015-2020) (K Units)
Figure 18. Global Artificial Cardiopulmonary Machine Market: Acute Respiratory Failure Treatment (2015-2020) ($ Millions)
Figure 19. Artificial Cardiopulmonary Machine Consumed in Others
Figure 20. Global Artificial Cardiopulmonary Machine Market: Others (2015-2020) (K Units)
Figure 21. Global Artificial Cardiopulmonary Machine Market: Others (2015-2020) ($ Millions)
Figure 22. Global Artificial Cardiopulmonary Machine Consumption Market Share by Application (2015-2020)
Figure 23. Global Artificial Cardiopulmonary Machine Value Market Share by Application (2015-2020)
Figure 24. Global Artificial Cardiopulmonary Machine Sales Market Share by Company in 2017
Figure 25. Global Artificial Cardiopulmonary Machine Sales Market Share by Company in 2019
Figure 26. Global Artificial Cardiopulmonary Machine Revenue Market Share by Company in 2017
Figure 27. Global Artificial Cardiopulmonary Machine Revenue Market Share by Company in 2019
Figure 28. Global Artificial Cardiopulmonary Machine Sale Price by Company in 2019
Figure 29. Global Artificial Cardiopulmonary Machine Consumption Market Share by Regions 2015-2020
Figure 30. Global Artificial Cardiopulmonary Machine Value Market Share by Regions 2015-2020
Figure 31. Americas Artificial Cardiopulmonary Machine Consumption 2015-2020 (K Units)
Figure 32. Americas Artificial Cardiopulmonary Machine Value 2015-2020 ($ Millions)
Figure 33. APAC Artificial Cardiopulmonary Machine Consumption 2015-2020 (K Units)
Figure 34. APAC Artificial Cardiopulmonary Machine Value 2015-2020 ($ Millions)
Figure 35. Europe Artificial Cardiopulmonary Machine Consumption 2015-2020 (K Units)
Figure 36. Europe Artificial Cardiopulmonary Machine Value 2015-2020 ($ Millions)
Figure 37. Middle East & Africa Artificial Cardiopulmonary Machine Consumption 2015-2020 (K Units)
Figure 38. Middle East & Africa Artificial Cardiopulmonary Machine Value 2015-2020 ($ Millions)
Figure 39. Americas Artificial Cardiopulmonary Machine Consumption Market Share by Countries in 2019
Figure 40. Americas Artificial Cardiopulmonary Machine Value Market Share by Countries in 2019
Figure 41. Americas Artificial Cardiopulmonary Machine Consumption Market Share by Type in 2019
Figure 42. Americas Artificial Cardiopulmonary Machine Consumption Market Share by Application in 2019
Figure 43. United States Artificial Cardiopulmonary Machine Consumption Growth 2015-2020 (K Units)
Figure 44. United States Artificial Cardiopulmonary Machine Value Growth 2015-2020 ($ Millions)
Figure 45. Canada Artificial Cardiopulmonary Machine Consumption Growth 2015-2020 (K Units)
Figure 46. Canada Artificial Cardiopulmonary Machine Value Growth 2015-2020 ($ Millions)
Figure 47. Mexico Artificial Cardiopulmonary Machine Consumption Growth 2015-2020 (K Units)
Figure 48. Mexico Artificial Cardiopulmonary Machine Value Growth 2015-2020 ($ Millions)
Figure 49. APAC Artificial Cardiopulmonary Machine Consumption Market Share by Countries in 2019
Figure 50. APAC Artificial Cardiopulmonary Machine Value Market Share by Regions in 2019
Figure 51. APAC Artificial Cardiopulmonary Machine Consumption Market Share by Type in 2019
Figure 52. APAC Artificial Cardiopulmonary Machine Consumption Market Share by Application in 2019
Figure 53. China Artificial Cardiopulmonary Machine Consumption Growth 2015-2020 (K Units)
Figure 54. China Artificial Cardiopulmonary Machine Value Growth 2015-2020 ($ Millions)
Figure 55. Japan Artificial Cardiopulmonary Machine Consumption Growth 2015-2020 (K Units)
Figure 56. Japan Artificial Cardiopulmonary Machine Value Growth 2015-2020 ($ Millions)
Figure 57. Korea Artificial Cardiopulmonary Machine Consumption Growth 2015-2020 (K Units)
Figure 58. Korea Artificial Cardiopulmonary Machine Value Growth 2015-2020 ($ Millions)
Figure 59. Southeast Asia Artificial Cardiopulmonary Machine Consumption Growth 2015-2020 (K Units)
Figure 60. Southeast Asia Artificial Cardiopulmonary Machine Value Growth 2015-2020 ($ Millions)
Figure 61. India Artificial Cardiopulmonary Machine Consumption Growth 2015-2020 (K Units)
Figure 62. India Artificial Cardiopulmonary Machine Value Growth 2015-2020 ($ Millions)
Figure 63. Australia Artificial Cardiopulmonary Machine Consumption Growth 2015-2020 (K Units)
Figure 64. Australia Artificial Cardiopulmonary Machine Value Growth 2015-2020 ($ Millions)
Figure 65. Europe Artificial Cardiopulmonary Machine Consumption Market Share by Countries in 2019
Figure 66. Europe Artificial Cardiopulmonary Machine Value Market Share by Countries in 2019
Figure 67. Europe Artificial Cardiopulmonary Machine Consumption Market Share by Type in 2019
Figure 68. Europe Artificial Cardiopulmonary Machine Consumption Market Share by Application in 2019
Figure 69. Germany Artificial Cardiopulmonary Machine Consumption Growth 2015-2020 (K Units)
Figure 70. Germany Artificial Cardiopulmonary Machine Value Growth 2015-2020 ($ Millions)
Figure 71. France Artificial Cardiopulmonary Machine Consumption Growth 2015-2020 (K Units)
Figure 72. France Artificial Cardiopulmonary Machine Value Growth 2015-2020 ($ Millions)
Figure 73. UK Artificial Cardiopulmonary Machine Consumption Growth 2015-2020 (K Units)
Figure 74. UK Artificial Cardiopulmonary Machine Value Growth 2015-2020 ($ Millions)
Figure 75. Italy Artificial Cardiopulmonary Machine Consumption Growth 2015-2020 (K Units)
Figure 76. Italy Artificial Cardiopulmonary Machine Value Growth 2015-2020 ($ Millions)
Figure 77. Russia Artificial Cardiopulmonary Machine Consumption Growth 2015-2020 (K Units)
Figure 78. Russia Artificial Cardiopulmonary Machine Value Growth 2015-2020 ($ Millions)
Figure 79. Middle East & Africa Artificial Cardiopulmonary Machine Consumption Market Share by Countries in 2019
Figure 80. Middle East & Africa Artificial Cardiopulmonary Machine Value Market Share by Countries in 2019
Figure 81. Middle East & Africa Artificial Cardiopulmonary Machine Consumption Market Share by Type in 2019
Figure 82. Middle East & Africa Artificial Cardiopulmonary Machine Consumption Market Share by Application in 2019
Figure 83. Egypt Artificial Cardiopulmonary Machine Consumption Growth 2015-2020 (K Units)
Figure 84. Egypt Artificial Cardiopulmonary Machine Value Growth 2015-2020 ($ Millions)
Figure 85. South Africa Artificial Cardiopulmonary Machine Consumption Growth 2015-2020 (K Units)
Figure 86. South Africa Artificial Cardiopulmonary Machine Value Growth 2015-2020 ($ Millions)
Figure 87. Israel Artificial Cardiopulmonary Machine Consumption Growth 2015-2020 (K Units)
Figure 88. Israel Artificial Cardiopulmonary Machine Value Growth 2015-2020 ($ Millions)
Figure 89. Turkey Artificial Cardiopulmonary Machine Consumption Growth 2015-2020 (K Units)
Figure 90. Turkey Artificial Cardiopulmonary Machine Value Growth 2015-2020 ($ Millions)
Figure 91. GCC Countries Artificial Cardiopulmonary Machine Consumption Growth 2015-2020 (K Units)
Figure 92. GCC Countries Artificial Cardiopulmonary Machine Value Growth 2015-2020 ($ Millions)
Figure 93. Global Artificial Cardiopulmonary Machine Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 94. Global Artificial Cardiopulmonary Machine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 95. Americas Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 96. Americas Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 97. APAC Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 98. APAC Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 99. Europe Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 100. Europe Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 101. Middle East & Africa Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 102. Middle East & Africa Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 103. United States Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 104. United States Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 105. Canada Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 106. Canada Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 107. Mexico Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 108. Mexico Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 109. Brazil Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 110. Brazil Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 111. China Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 112. China Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 113. Japan Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 114. Japan Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 115. Korea Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 116. Korea Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 117. Southeast Asia Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 118. Southeast Asia Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 119. India Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 120. India Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 121. Australia Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 122. Australia Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 123. Germany Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 124. Germany Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 125. France Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 126. France Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 127. UK Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 128. UK Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 129. Italy Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 130. Italy Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 131. Russia Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 132. Russia Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 133. Spain Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 134. Spain Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 135. Egypt Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 136. Egypt Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 137. South Africa Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 138. South Africa Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 139. Israel Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 140. Israel Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 141. Turkey Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 142. Turkey Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 143. GCC Countries Artificial Cardiopulmonary Machine Consumption 2021-2025 (K Units)
Figure 144. GCC Countries Artificial Cardiopulmonary Machine Value 2021-2025 ($ Millions)
Figure 145. LivaNova (Sorin) Artificial Cardiopulmonary Machine Market Share (2018-2020)
Figure 146. Getinge (Maquet) Artificial Cardiopulmonary Machine Market Share (2018-2020)
Figure 147. Terumo CV Group Artificial Cardiopulmonary Machine Market Share (2018-2020)
Figure 148. Braile Biomedica Artificial Cardiopulmonary Machine Market Share (2018-2020)
Figure 149. Medtronic Artificial Cardiopulmonary Machine Market Share (2018-2020)
Figure 150. Tianjin Medical Artificial Cardiopulmonary Machine Market Share (2018-2020)
